Alzheimer’s disease is a condition that slowly damages the brain, leading to memory loss and difficulty thinking clearly. One of the key features of this disease is inflammation in the brain.
This inflammation is caused by the brain’s own immune system, which becomes too active and starts to harm healthy cells.
The brain’s immune system is designed to protect us. It reacts to infections and damage by triggering a defense response. But in Alzheimer’s disease, this response does not turn off properly. Instead, it stays active for a long time, leading to ongoing inflammation that damages brain cells and their connections.
A study published in Cell Chemical Biology on April 23, 2026, by researchers at Scripps Research has uncovered an important mechanism behind this process. The scientists focused on a protein called STING, which plays a key role in the immune system.
Under normal conditions, STING helps detect harmful signals and activates a protective response. However, the researchers found that in Alzheimer’s disease, STING becomes overactive due to a chemical modification called S-nitrosylation.
This chemical process involves nitric oxide, a small molecule produced in the body. When nitric oxide attaches to a specific part of the STING protein, it changes the protein’s behavior. The researchers identified the exact location of this change at cysteine 148.
When this site is modified, STING becomes overactive and triggers strong inflammation. The researchers observed high levels of this altered protein in brain samples from people with Alzheimer’s, as well as in laboratory-grown human brain cells and mouse models.
The study also revealed that harmful protein clumps found in Alzheimer’s disease, such as amyloid-beta and alpha-synuclein, can trigger this chemical change. This creates a cycle in which protein buildup leads to inflammation, which then causes more chemical changes and even more inflammation.
To test whether this process could be stopped, the researchers created a version of STING that could not undergo this chemical modification. When this version was used in mice, the results were promising. The mice showed reduced inflammation in the brain, and their nerve cell connections were preserved.
These connections, known as synapses, are essential for communication between brain cells. Their loss is strongly linked to memory problems and cognitive decline. By protecting synapses, the modified STING protein helped maintain brain function.
An important advantage of this approach is that it does not block the immune system completely. The normal protective role of STING remains intact, while the harmful overactivation is reduced. This balance is important because the immune system is still needed to fight infections.
Despite these encouraging results, the study has limitations. It was conducted in laboratory settings and animal models. Human biology is more complex, and further research is needed to confirm whether the same mechanism applies in patients.
The findings are significant because they identify a specific target for future drug development. Instead of broadly reducing inflammation, scientists may be able to design treatments that focus on this precise molecular switch.
In summary, this research offers a new way to understand Alzheimer’s disease. It shows that a small chemical change in a single protein can have a large impact on brain inflammation and cell health.
From a scientific point of view, the study is strong in its detailed analysis and use of multiple models. However, it is still at an early stage. More studies, especially in humans, are needed before this approach can be used in treatment.
Overall, the discovery of this molecular switch provides a promising direction for future therapies aimed at slowing or preventing Alzheimer’s disease.
If you care about Alzheimer’s disease, please read studies that bad lifestyle habits can cause Alzheimer’s disease, and strawberries can be good defence against Alzheimer’s.
For more information about brain health, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
Source: Scripps Research.
